Table 1.

Baseline characteristics of the patients with or without acute CRS

Variables	AKI		No AKI		p value
	ACS (n = 36)	ADHF (n = 35)	ACS (n = 200)	ADHF (n = 18)	p*	p**	p
Demographic characteristics
Age, years	68.58 ± 10.56	75.29 ± 10.71	59.86 ± 12.50	74.72 ± 10.56	0.00	0.85	0.08
Male sex	26 (72.2)	12 (66.7)	151 (75.5)	13 (37.1)	0.67	0.49	0.023
BMI	27.05 ± 3.43	26.16 ± 5.81	27.50 ± 3.46	25.93 ± 4.22	0.47	0.86	0.22
Comorbidities
Hypertension	26 (72.2)	17 (94.4)	103 (51.5)	28 (80.0)	0.02	0.24	0.002
Diabetes mellitus	16 (44.4)	12 (66.7)	60 (30.0)	19 (54.3)	0.12	0.55	0.010
Chronic kidney disease	19 (9.5)	14 (77.8)	13 (36.1)	24 (68.6)	0.00	0.53	0.000
Previous CVA	6 (16.7)	1 (5.6)	15 (7.5)	5 (14.3)	0.10	0.65	0.058
Previous MI	55 (27.5)	5 (27.8)	15 (41.7)	7 (20.0)	0.11	0.73	0.650
Previous coronary revascularization	19 (9.5)	4 (22.2)	6 (16.7)	7 (20.0)	0.23	1.00	0.099
Smoking history	17 (47.2)	6 (33.3)	114 (57.0)	13 (37.1)	0.28	1.00	0.075
Selected medications
ACEi	13 (36.1)	10 (38.9)	73 (36.5)	7 (28.6)	1.00	0.53	0.569
ARB	7 (19.4)	5 (27.8)	24 (12.0)	9 (25.7)	0.28	1.00	0.088
β-blocker	13 (36.1)	9 (50.0)	81 (40.5)	14 (40.0)	0.71	0.56	0.678
Furosemide	4 (11.1)	6 (33.3)	11 (5.5)	13 (37.1)	0.25	1.00	0.001
HCTZ	11 (30.6)	7 (38.9)	19 (9.5)	20 (57.1)	0.02	0.25	0.000
Length of hospital stay, days	6.75 ± 3.16	6.71 ± 3.33	4.67 ± 2.10	6.67 ± 4.22	0.00	0.96	0.002

Values are mean ± SD or numbers and percentages in parentheses.

CVA = Cerebrovascular accident;

MI = myocardial infarction;

ACEi = angiotensin converting enzyme inhibitor;

ARB = angiotensin receptor blocker;

HCTZ = hydrochlorothiazide.

p = AKI vs. no-AKI patients;

p* = for ACS patients, with vs. without AKI.

p** = for ADHF patients, with vs. without AKI. B values are statistically significant.